Events & Conferences

Meet OncoBeta at Booth 218 Join the OncoBeta team at EANM 2026 in Vienna to discuss clinical evidence, treatment center implementation and multidisciplinary collaboration in non-melanoma skin cancer. Book a Meeting Visit Congress Get Directions Connect with the OncoBeta Team at EANM: GLOBAL MANAGEMENT Dr. Cody Allison Chief Executive Officer Shannon Brown Chief Commercial Officer […]

Meet OncoBeta at ICPO OncoBeta is pleased to participate in the International Centers for Precision Oncology (ICPO) community, bringing together experts committed to advancing theranostics, education and patient access worldwide. ICPO plays an important role in supporting clinical excellence, education and collaboration across the global theranostics ecosystem. Through its international network of centers, educational initiatives […]

Meet OncoBeta at ADO OncoBeta is pleased to attend the Annual Meeting of the Working Group for Dermatological Oncology (ADO), one of Germany’s leading scientific meetings dedicated to skin cancer and dermato-oncology. The congress brings together dermatologists, oncologists, surgeons and researchers focused on advancing skin cancer prevention, diagnosis, treatment and long-term patient care. As one […]

Australian sub-analysis of the EPIC-Skin Study presented at ACD ASM 2026 At the 58th Annual Scientific Meeting of the Australasian College of Dermatologists (ACD ASM) in Melbourne, Australia, OncoBeta presented an Australian sub-analysis from the Phase IV EPIC-Skin Study. The presentation, delivered by A/Prof Chris Baker, provided insights into Australian patient outcomes and clinical experience […]

Dermatology-directed assessment of two-year efficacy, safety and skin findings from the EPIC-Skin Study At the 22nd EADO Congress in Prague, OncoBeta presented a dermatology-directed analysis of the Phase IV EPIC-Skin Study. The poster highlighted two-year efficacy and safety outcomes following Rhenium-SCT® treatment for non-melanoma skin cancer, including an independent dermatology assessment of skin findings, healing […]

Two-year EPIC Skin Study results presented at ACRO 2026 OncoBeta presented final 24-month outcomes from the Phase IV EPIC Skin Study at the American College of Radiation Oncology (ACRO) 2026 Annual Meeting during a scientific breakfast symposium. The data, presented by A/Prof Siddhartha Baxi, showed durable clinical response, tolerability, cosmetic outcomes and patient-reported experience following […]